NASDAQ
27.02.26 | 21:49
4,790 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 11.02. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| KORU MEDICAL SYSTEMS Aktie jetzt für 0€ handeln | |||||
| 29.01. | KORU Medical's infusion system cleared for UCB's RYSTIGGO therapy | 7 | Investing.com | ||
| 12.01. | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 12.01. | KORU Medical Systems sees Q4 revenue of $10.9M | 1 | Seeking Alpha | ||
| 03.01. | KORU Medical Systems, Inc. - S-8, Securities to be offered to employees in employee benefit plans | - | SEC Filings | ||
| 30.12.25 | KORU Medical beantragt FDA-Zulassung für Gerät zur Brustkrebstherapie | 1 | Investing.com Deutsch | ||
| 30.12.25 | KORU Medical submits FDA application for breast cancer therapy device | 2 | Investing.com | ||
| 25.11.25 | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 17.11.25 | KORU Medical Systems to Present Promising Results on the Use of the FreedomEDGE Syringe Infusion System in Infusion Centers at ESID/EHA/SIOPE Focused Symposium 2025 | 365 | Business Wire | KORU Medical Systems, Inc. (NASDAQ: KRMD) ("KORU Medical" or the "Company"), a leading medical technology company focused on innovative and patient-centric large volume subcutaneous infusion solutions... ► Artikel lesen | |
| 13.11.25 | Koru Medical Systems stock maintains Buy rating at Canaccord on strong growth | 1 | Investing.com | ||
| 13.11.25 | KORU Medical Systems projects 20%-22% revenue growth for 2025 while advancing oncology and international expansion | 3 | Seeking Alpha | ||
| 12.11.25 | KORU Medical übertrifft im Q3 2025 die Umsatzerwartungen und hebt Prognose an | 2 | Investing.com Deutsch | ||
| 12.11.25 | KORU Medical Systems Non-GAAP EPS of $0.00 beats by $0.02, revenue of $10.4M beats by $0.73M | 5 | Seeking Alpha | ||
| 12.11.25 | KORU Medical Systems, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 18.09.25 | ForCast Orthopedics And KORU Medical Partner On Novel Antibiotic Infusion Therapy | 3 | RTTNews | ||
| 18.09.25 | ForCast Orthopedics and KORU Medical Systems Announce Agreement for Novel Antibiotic Infusion Therapy | 312 | ACCESS Newswire | DENVER, CO AND MAHWAH, NJ / ACCESS Newswire / September 18, 2025 / ForCast Orthopedics, Inc. and KORU Medical Systems, Inc. (NASDAQ:KRMD) today jointly announced an agreement leveraging KORU Medical's... ► Artikel lesen |
16 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| ALIGNMENT HEALTHCARE | 19,220 | 0,00 % | Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics | Delivers full-year revenue of $3.95 billion, representing 46.1% growth year-over-year Exceeds high-end of fourth quarter and full-year guidance across all key metrics: membership, revenue, adjusted... ► Artikel lesen | |
| FRESENIUS MEDICAL CARE | 39,610 | +0,99 % | Fresenius Medical Care mit deutlichem Rücksetzer - was steckt dahinter? | Fresenius Medical Care geriet nach einem Stimmungswechsel deutlich unter Druck. Kann sich die Aktie nun oberhalb der Unterstützung von Mitte Januar stabilisieren Den vollständigen Artikel lesen ... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 41,470 | -2,17 % | RBC stuft Siemens Healthineers auf 'Outperform' | NEW YORK (dpa-AFX Analyser) - Die kanadische Bank RBC hat Siemens Healthineers mit einem Kursziel von 55 Euro auf "Outperform" belassen. Die Nervosität der Anleger vor einem möglichen Verkauf des Diagnostikgeschäfts... ► Artikel lesen | |
| FRESENIUS | 50,30 | -1,99 % | Fresenius: Weiteres Wachstum in Sicht - Aktie bärenstark | Am kommenden Mittwoch (25. Februar) wird der Gesundheitskonzern Fresenius die Zahlen für das vergangene vierte Quartal respektive Gesamtjahr 2025 vorlegen. Der Markt rechnet sowohl umsatz- als auch... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 41,380 | 0,00 % | BrightSpring Health Services, Inc. Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Full Year 2026 Guidance | LOUISVILLE, Ky., Feb. 27, 2026 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 22,670 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter 2025 Financial Results and Updates 2026 Revenue Guidance | SAN JOSE, Calif., Feb. 25, 2026 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics® Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| PROGYNY | 17,685 | 0,00 % | Progyny, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| GENEDX | 79,77 | 0,00 % | These Analysts Slash Their Forecasts On GeneDx After Q4 Results | ||
| GERRESHEIMER | 16,640 | +5,99 % | Gerresheimers Abschluss unter dem Röntgenblick der BaFin | Die BaFin verschärft den Blick auf die Rechnungslegung der Gerresheimer AG. Sie kündigt an, die am 18.09.2025 gestartete Anlassprüfung des offengelegten Konzernabschlusses und Konzernlageberichts 2023/2024... ► Artikel lesen | |
| ONEMEDNET | 1,030 | 0,00 % | OneMedNet-Aktie steigt nach Plattform-Launch um 90 % | ||
| CARL ZEISS MEDITEC | 26,400 | -3,23 % | Carl Zeiss Meditec AG: ZEISS launches Collaborative Care application to strengthen continuity of care; new solution offers on-premises and cloud-based options | Built on the ZEISS Health Data Platform, ZEISS Collaborative Care offers eye care professionals a flexible way to collaborate - whether as a standalone cloud application or as an integrated... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,730 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2025 Financial Results | All 2025 Operating and Financial Metrics At or Above High End of Guidance RangesFull-year 2025 Net Income +59.3% from 2024Full-year 2025 Adjusted EBITDA of $125.5 Million, +38.8% from 2024Full-year... ► Artikel lesen | |
| PACS GROUP | 36,475 | 0,00 % | Truist raises PACS Group stock price target to $50 on margin strength | ||
| ADAPTHEALTH | 9,155 | 0,00 % | Leerink cuts AdaptHealth stock price target on 2025 earnings decline | ||
| ESSILORLUXOTTICA | 221,20 | -1,69 % | FedEx, EssilorLuxottica sued by customers for tariff refunds |
KORU MEDICAL SYSTEMS INC gehört der Branche Gesundheitswesen an. Der aktuelle Kurs liegt bei 4,790 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu KORU MEDICAL SYSTEMS INC finden Sie auf Wallstreet Online.